Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03612232
Title Cabozantinib in Advanced Adrenocortical Carcinoma (CaboACC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wuerzburg University Hospital
Indications

adrenocortical carcinoma

Therapies

Cabozantinib

Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.